NCT06733753Recruiting
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules: A Multicenter Study
Source: ClinicalTrials.gov · Last updated 14 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 7 Dec 2024
- Start date
- 9 Dec 2024
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Chinese PLA General Hospital
- NCT number
- NCT06733753
What you commit to
- Study type: Observational
- Planned participants: 600
- From 9 Dec 2024 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- follicular neoplasm or malignancy findings on biopsy
- no suspicious of malignancy in US
Other
- patients with contra-lateral vocal cord paralysis
- follow- up time less than 12 months
Who the study is looking for
- confirmation of Bethesda III or IV on fine- needle aspiration and negative on Braf V600E test
- no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
- refusal or ineligibility for surgery
- follow-up time ≥12 months
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese PLA General Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.